Direct medical costs and source of cost differences across the spectrum of cognitive decline: A population-based study

Alzheimer's and Dementia

Volumn 11, Issue 8, 2015, Pages 917-932

  Leibson, Cynthia L ^a   Long, Kirsten Hall ^b   Ransom, Jeanine E ^a   Roberts, Rosebud O ^a   Hass, Steven L ^c   Duhig, Amy M ^c   Smith, Carin Y ^a   Emerson, Jane A ^a   Pankratz, V Shane ^a   Petersen, Ronald C ^a  

^a MAYO CLINIC   (United States)

^b Long Health Economics Consulting   (United States)

^c ABBVIE INC   (United States)

Author keywords

Cognitive status; Cost; Dementia; Economics; Mild cognitive impairment; Utilization

Indexed keywords

AGE; AGED; ARTICLE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEMENTIA; EDUCATION; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; POPULATION RESEARCH; PRIORITY JOURNAL; SEX; VERY ELDERLY; AGING; COGNITION DISORDERS; CROSS-SECTIONAL STUDY; DISEASE COURSE; ECONOMICS; FACTUAL DATABASE; HEALTH CARE PLANNING; PATIENT ATTITUDE; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED; AGED, 80 AND OVER; AGING; COGNITION DISORDERS; COMMUNITY HEALTH PLANNING; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DEMENTIA; DISEASE PROGRESSION; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 84939265626     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.01.007     Document Type: Article

References (84)

1. A. Wimo, L. Jonsson, J. Bond, M. Prince, B. Winblad on behalf of Alzheimer Disease International The worldwide economic impact of dementia 2010 Alzheimers Dement 9 2013 1 11
2. Alzheimer's Disease International. The global voice on dementia. Alzheimer's statistics. Available at: http://www.alz.co.uk/research/statistics. Accessed August 18, 2014.
3. Alzheimer's Association. 2014 Alzheimer's disease facts and figures. Available at: http://www.alz.org/downloads/Facts-Figures-2014.pdf. Accessed September 21, 2014.
4. U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation. National plan to address Alzheimer's disease: 2014 Update. Available at: http://aspe.hhs.gov/daltcp/napa/NatlPlan2014.pdf. Accessed September 21, 2014.
5. P.J. Lin, Z. Yang, H.M. Fillit, J.T. Cohen, and P.J. Neumann Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's disease Health Aff (Millwood) 33 2014 547 554
6. C. Valcarcel-Nazco, L. Perestelo-Perez, J.L. Molinuevo, J. Mar, I. Castilla, and P. Serrano-Aguilar Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease J Alzheimers Dis 42 2014 777 788
7. K.H. Long, J.P. Moriarty, M.S. Mittelman, and S.S. Foldes Estimating the potential cost savings from the New York University Caregiver Intervention in Minnesota Health Aff (Millwood) 33 2014 596 604
8. A. Skoldunger, K. Johnell, B. Winblad, and A. Wimo Mortality and treatment costs have a great impact on the cost-effectiveness of disease modifying treatment in Alzheimer's disease - a simulation study Curr Alzheimer Res 10 2013 207 216
9. D. Getsios, S. Blume, K.J. Ishak, G. Maclaine, and L. Hernandez An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom Alzheimers Dement 8 2012 22 30
10. Z. Yang, K. Zhang, P.J. Lin, C. Clevenger, and A. Atherly A longitudinal analysis of the lifetime cost of dementia Health Serv Res 47 2012 1660 1678
11. D. Budd, L.C. Burns, Z. Guo, G. L'Italien, and P. Lapuerta Impact of early intervention and disease modification in patients with predementia Alzheimer's disease: a Markov model simulation Clinicoecon Outcomes Res 3 2011 189 195
12. M. Kasuya, and K. Meguro Health economic effect of donepezil treatment for CDR 0.5 converters to Alzheimer's disease as shown by the Markov model Arch Gerontol Geriatr 50 2010 295 299
13. D.L. Weimer, and M.A. Sager Early identification and treatment of Alzheimer's disease: social and fiscal outcomes Alzheimers Dement 5 2009 215 226
14. L. Jonsson, P. Lindgren, A. Wimo, B. Jonsson, and B. Winblad Costs of Mini Mental State Examination-related cognitive impairment Pharmacoeconomics 16 1999 409 416
15. R. Brookmeyer, S. Gray, and C. Kawas Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset Am J Public Health 88 1998 1337 1342
16. P.J. Lin, D.I. Kaufer, M.L. Maciejewski, R. Ganguly, J.E. Paul, and A.K. Biddle An examination of Alzheimer's disease case definitions using Medicare claims and survey data Alzheimers Dement 6 2010 334 341
17. D.H. Taylor Jr., T. Ostbye, K.M. Langa, D. Weir, and B.L. Plassman The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited J Alzheimers Dis 17 2009 807 815
18. R. Newcomer, T. Clay, J.S. Luxenberg, and R.H. Miller Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records J Am Geriatr Soc 47 1999 215 219
19. J.W. Hill, R. Futterman, S. Duttagupta, V. Mastey, J.R. Lloyd, and H. Fillit Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare Neurology 58 2002 62 70
20. C.G. Lyketsos, J.M. Sheppard, and P.V. Rabins Dementia in elderly persons in a general hospital Am J Psychiatry 157 2000 704 707
21. M. Weiner, N.R. Powe, W.E. Weller, T.J. Shaffer, and G.F. Anderson Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns J Am Geriatr Soc 46 1998 762 770
22. S.M. Albert, S. Glied, H. Andrews, Y. Stern, and R. Mayeux Primary care expenditures before the onset of Alzheimer's disease Neurology 59 2002 573 578
23. M.D. Hurd, P. Martorell, A. Delavande, K.J. Mullen, and K.M. Langa Monetary costs of dementia in the United States N Engl J Med 368 2013 1326 1334
24. J.P. Bynum The long reach of Alzheimer's disease: patients, practice, and policy Health Aff (Millwood) 33 2014 534 540
25. P.J. Lin, and P.J. Neumann The economics of mild cognitive impairment Alzheimers Dement 9 2013 58 62
26. R.A. Sperling, C.R. Jack Jr., and P.S. Aisen Testing the right target and right drug at the right stage Sci Transl Med 3 2011 111cm33
27. National Institute on Aging. 2012-2013 Alzheimer's disease progress report: seeking the earliest interventions. Available at: http://www.nia.nih.gov/alzheimers/publication/2012-2013-alzheimers-disease-progress-report. Accessed September 21, 2014.
28. C.W. Zhu, M. Sano, S.H. Ferris, P.J. Whitehouse, M.B. Patterson, and P.S. Aisen Health-related resource use and costs in elderly adults with and without mild cognitive impairment J Am Geriatr Soc 61 2013 396 402
29. M. Luppa, S. Heinrich, H. Matschinger, A. Hensel, T. Luck, S.G. Riedel-Heller, and et al. Direct costs associated with mild cognitive impairment in primary care Int J Geriatr Psychiatry 23 2008 963 971
30. A. Wimo, and B. Winblad Pharmacoeconomics of mild cognitive impairment Acta Neurol Scand Suppl 179 2003 94 99
31. B. Winblad, K. Palmer, M. Kivipelto, V. Jelic, L. Fratiglioni, L.O. Wahlund, and et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment J Intern Med 256 2004 240 246
32. R.C. Petersen Mild cognitive impairment as a diagnostic entity J Intern Med 256 2004 183 194
33. J.L. St Sauver, B.R. Grossardt, B.P. Yawn, L.J. Melton 3rd, and W.A. Rocca Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project Am J Epidemiol 173 2011 1059 1068
34. L.J. Melton 3rd History of the Rochester Epidemiology Project Mayo Clin Proc 71 1996 266 274
35. R.O. Roberts, Y.E. Geda, D.S. Knopman, R.H. Cha, V.S. Pankratz, B.F. Boeve, and et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics Neuroepidemiology 30 2008 58 69
36. C.L. Leibson, S.K. Katusic, W.J. Barbaresi, J. Ransom, and P.C. O'Brien Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder JAMA 285 2001 60 66
37. Alzheimer's Association. Changing the trajectory of Alzheimer's disease: a national imperative. Available at: http://www.alz.org/documents-custom/trajectory-appendix-a.pdf. Accessed September 21, 2014.
38. D.S. Knopman, R.C. Petersen, W.A. Rocca, E.B. Larson, and M. Ganguli Passive case-finding for Alzheimer's disease and dementia in two U.S. communities Alzheimers Dement 7 2011 53 60
39. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 4th ed. 1994 American Psychiatric Association Washington, DC
40. D.S. Knopman, R.O. Roberts, Y.E. Geda, V.S. Pankratz, T.J. Christianson, R.C. Petersen, and et al. Validation of the telephone interview for cognitive status-modified in subjects with normal cognition, mild cognitive impairment, or dementia Neuroepidemiology 34 2010 34 42
41. J.C. Morris The Clinical Dementia Rating (CDR): current version and scoring rules Neurology 43 1993 2412 2414
42. R.I. Pfeffer, T.T. Kurosaki, C.H. Harrah Jr., J.M. Chance, and S. Filos Measurement of functional activities in older adults in the community J Gerontol 37 1982 323 329
43. E. Kokmen, G.E. Smith, R.C. Petersen, E. Tangalos, and R.C. Ivnik The short test of mental status. Correlations with standardized psychometric testing Arch Neurol 48 1991 725 728
44. R.J. Ivnik, J.F. Malec, G.E. Smith, E.G. Tangalos, R.C. Petersen, E. Kokmen, and et al. Mayo's Older Americans Normative Studies: WAIS-R, WMS-R and AVLT norms for ages 56 through 97 Clin Neuropsychol 6 1992 1 30
45. R.C. Petersen, R.O. Roberts, D.S. Knopman, Y.E. Geda, R.H. Cha, V.S. Pankratz, and et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging Neurology 75 2010 889 897
46. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, A.M. Fagan, and et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
47. K.A. Welsh, J.C.S. Breitner, and K.M. Magruder-Habib Detection of dementia in the elderly using telephone screening of cognitive status Neuropsychiatry Neuropsychol Behav Neurol 6 1993 103 110
48. S.E. Cook, M. Marsiske, and K.J. McCoy The use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the detection of amnestic mild cognitive impairment J Geriatr Psychiatry Neurol 22 2009 103 109
49. The Dartmouth Institute for Health Policy & Clinical Practice. Dartmouth Atlas of Healthcare. Available at: http://www.dartmouthatlas.org/. Accessed September 21, 2014.
50. J.L. Wagner, S.R. Alberts, J.A. Sloan, S. Cha, J. Killian, M.J. O'Connell, and et al. Incremental costs of enrolling cancer patients in clinical trials: a population-based study J Natl Cancer Inst 91 1999 847 853
51. L.J. Melton 3rd The threat to medical-records research N Engl J Med 337 1997 1466 1470
52. Government Printing Office. Public Law 111-148-Mar.23, 2010. Available at: http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed September 21, 2014.
53. Centers for Disease Control and Prevention. International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM). Available at: http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed September 21, 2014.
54. ® System 2010 Available at http://www.acg.jhsph.org/ Accessed September 21, 2014
55. ® System: Excerpt from Technical Reference Guide, Version 9.0 2009 Johns Hopkins Blomberg School of Public Health Baltimore, MD Available at: http://www.healthpartners.com/ucm/groups/public/@hp/@public/documents/documents/dev-057914.pdf. Accessed September 21, 2014.
56. K.H. Long, A. Rubio-Tapia, A.E. Wagie, L.J. Melton 3rd, B.D. Lahr, C.T. Van Dyke, and et al. The economics of coeliac disease: a population-based study Aliment Pharmacol Ther 32 2010 261 269
57. C.L. Leibson, K.H. Long, D.M. Maraganore, J.H. Bower, J.E. Ransom, P.C. O'Brien, and et al. Direct medical costs associated with Parkinson's disease: a population-based study Mov Disord 21 2006 1864 1871
58. S.E. Gabriel, A.N. Tosteson, C.L. Leibson, C.S. Crowson, G.R. Pond, C.S. Hammond, and et al. Direct medical costs attributable to osteoporotic fractures Osteoporos Int 13 2002 323 330
59. C.E. Begley, M. Famulari, J.F. Annegers, D.R. Lairson, T.F. Reynolds, S. Coan, and et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data Epilepsia 41 2000 342 351
60. H.G. Birnbaum, R. Ben-Hamadi, P.E. Greenberg, M. Hsieh, J. Tang, and C. Reygrobellet Determinants of direct cost differences among US employees with major depressive disorders using antidepressants Pharmacoeconomics 27 2009 507 517
61. J. Mullahy Much ado about two: reconsidering retransformation and the two-part model in health econometrics J Health Econ 17 1998 247 281
62. D. Esposito, A.D. Bagchi, J.M. Verdier, D.S. Bencio, and M.S. Kim Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs Am J Manag Care 15 2009 437 445
63. A. Basu, B.V. Arondekar, and P.J. Rathouz Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity Health Econ 15 2006 1091 1107
64. Cohen SB, Uberoi N. Differentials in the concentration in the level of health expenditures across population subgroups in the U.S., 2010 Medical Expenditure Panel Survey. Statistical Brief #471, August 2013. Available at: http://meps.ahrq.gov/mepsweb/data-files/publications/st421/stat421.shtml. Accessed September 21, 2014.
65. E. Caspi, N.M. Silverstein, F. Porell, and N. Kwan Physician outpatient contacts and hospitalizations among cognitively impaired elderly Alzheimers Dement 5 2009 30 42
66. V.L. Lamb, F.A. Sloan, and A.S. Nathan Dementia and Medicare at life's end Health Serv Res 43 2008 714 732
67. P. Ayyagari, M. Salm, and F.A. Sloan Effects of diagnosed dementia on Medicare and Medicaid program costs Inquiry 44 2007 481 494
68. C. Leibson, T. Owens, P. O'Brien, S. Waring, E. Tangalos, V. Hanson, and et al. Use of physician and acute care services by persons with and without Alzheimer's disease: a population-based comparison J Am Geriatr Soc 47 1999 864 869
69. Z. Feng, L.A. Coots, Y. Kaganova, and J.M. Wiener Hospital and ED use among medicare beneficiaries with dementia varies by setting and proximity to death Health Aff (Millwood) 33 2014 683 690
70. C.M. Callahan, H.C. Hendrie, and W.M. Tierney Documentation and evaluation of cognitive impairment in elderly primary care patients Ann Intern Med 122 1995 422 429
71. E.A. Phelan, S. Borson, L. Grothaus, S. Balch, and E.B. Larson Association of incident dementia with hospitalizations JAMA 307 2012 165 172
72. P.J. Lin, A.K. Biddle, R. Ganguly, D.I. Kaufer, and M.L. Maciejewski The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer disease and related dementias Med Care 47 2009 1174 1179
73. E.D. Eaker, S.F. Mickel, P.H. Chyou, N.J. Mueller-Rizner, and J.P. Slusser Alzheimer's disease or other dementia and medical care utilization Ann Epidemiol 12 2002 39 45
74. N.R. Fowler Accurate assessments of healthcare use along the course of cognitive decline J Am Geriatr Soc 61 2013 450 451
75. D.O. Clark, M. Von Korff, K. Saunders, W.M. Baluch, and G.E. Simon A chronic disease score with empirically derived weights Med Care 33 1995 783 795
76. J.L. St Sauver, B.R. Grossardt, C.L. Leibson, B.P. Yawn, L.J. Melton 3rd, and W.A. Rocca Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project Mayo Clin Proc 87 2012 151 160
77. Centers for Medicare & Medicaid Services. Minimum Data Set (MDS) - Version 2.0 for Nursing Home Resident Assessment and Care Screening. Available at: http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/NursingHomeQualityInits/downloads/MDS20MDSAllForms.pdf. Accessed September 21, 2014.
78. J. Emerson, C. Smith, R. Roberts, S. Hass, A. Duhig, V. Pankratz, and et al. Nursing home use and dependency across the full trajectory of cognitive decline: normal, mild cognitive impairment, newly discovered, and prevalent dementia Arch Clin Neuropsychol 28 2013 592 593
79. J.P. Bynum, P.V. Rabins, W. Weller, M. Niefeld, G.F. Anderson, and A.W. Wu The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use J Am Geriatr Soc 52 2004 187 194
80. D.P. Goldman, D. Cutler, J.W. Rowe, P.C. Michaud, J. Sullivan, D. Peneva, and et al. Substantial health and economic returns from delayed aging may warrant a new focus for medical research Health Aff (Millwood) 32 2013 1698 1705
81. Y.E. Geda, R.O. Roberts, D.S. Knopman, R.C. Petersen, T.J. Christianson, V.S. Pankratz, and et al. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study Arch Gen Psychiatry 65 2008 1193 1198
82. Y.E. Geda, L.S. Schneider, L.N. Gitlin, D.S. Miller, G.S. Smith, J. Bell, and et al. Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future Alzheimers Dement 9 2013 602 608
83. C.G. Lyketsos, M.C. Carrillo, J.M. Ryan, A.S. Khachaturian, P. Trzepacz, J. Amatniek, and et al. Neuropsychiatric symptoms in Alzheimer's disease Alzheimers Dement 7 2011 532 539
84. M.B. Buntin, and A.M. Zaslavsky Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures J Health Econ 23 2004 525 542